@article{e75f306c81a24a099cb735c45eecc072,
title = "2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)",
keywords = "ACC/AHA Clinical Data Standards, acute coronary syndrome, clinical trials, coronary artery bypass graft, coronary artery disease, coronary revascularization, percutaneous coronary intervention",
author = "Dehmer, \{Gregory J.\} and Vinay Badhwar and Bermudez, \{Edmund A.\} and Cleveland, \{Joseph C.\} and Cohen, \{Mauricio G.\} and D'Agostino, \{Richard S.\} and Ferguson, \{T. Bruce\} and Hendel, \{Robert C.\} and Isler, \{Maria Lizza\} and Jacobs, \{Jeffrey P.\} and Hani Jneid and Katz, \{Alan S.\} and Maddox, \{Thomas M.\} and Shahian, \{David M.\}",
note = "Funding Information: Heart disease is the leading cause of death in the United States ( 1 ), and coronary artery disease is the most common type of heart disease ( 2 ). The annual estimated cost of heart disease in the United States is \$218 billion ( 3 ). A substantial portion of this expense is related to the cost of hospitalizations for interventional cardiology and cardiac surgery ( 3 ). As healthcare costs continue to rise, increased emphasis is placed on the need to develop platforms to measure outcomes, quality, and value in medicine and surgery. Large databases, such as the Society of Thoracic Surgeons (STS) National Database, the ACC National Cardiovascular Data Registry (NCDR), and the Get With The Guidelines–Coronary Artery Disease database, contain a wealth of information on cardiac surgical procedures, invasive cardiac procedures, and selected clinical conditions but do not contain information about healthcare economics (charges and costs) and only limited data on longitudinal outcome. To address these limitations, the STS and NCDR metrics must be linked to other sources of data such as Centers for Medicare and Medicaid Services data. Such linkages of large data sets facilitate comparative effectiveness research as well as the study of longitudinal outcomes and healthcare economics, as exemplified by the ASCERT (American College of Cardiology Foundation–Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies) trial of coronary artery bypass grafting and percutaneous coronary intervention, funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health ( 4–6 ). The success of this type of research, using linked data sets, depends on the harmonization of clinical data standards and definitions across databases. The purpose of this article is to publish consensus-based key data elements and definitions for databases capturing information about coronary revascularization. ",
year = "2020",
month = apr,
day = "28",
doi = "10.1016/j.jacc.2020.02.010",
language = "English (US)",
volume = "75",
pages = "1975--2088",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "16",
}